Skip to main content
RPRX logo

RPRX · Royalty Pharma plc · Short Interest

Track RPRX — free
$63.86 +0.11 (+0.17%) At close · Oct 23
Market Cap
$36.72B
Shares
575.00M
Volume · Oct 23 4.02M Avg daily vol (3M) 3M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

RPRX Latest Reported Short Interest

FINRA reported 12,885,147 RPRX shares sold short as of the September 30, 2026 settlement date, an increase of 1,237,582 shares. Days to cover was 4.44 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

RPRX Short Interest Forecast

Equibles' model estimates 12,902,283 shares sold short for the October 15, 2026 settlement, +0.1% versus the latest reported position, with a likely range of 11,170,636 to 14,642,585 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 Low confidence 63% chance it falls
12,902,283 +0.1% vs reported
Likely range 11,170,636 to 14,642,585 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
60/100
Short interest 2.2% of shares — P51 Days to cover 4.4 — P65 Price vs VWAP +7.5% — P89 Short-volume trend -2.6% — P41 Short interest change +10.6% — P73 Worst FTD 0.01% of shares — P53

Positioning score 60.4 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-26 05:55 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 12,885,147 11,647,565 +1,237,582 4.44
2026-09-15 11,647,565 11,903,716 -256,151 3.25
2026-08-31 11,903,716 11,606,728 +296,988 5.05
2026-08-14 11,606,728 10,667,818 +938,910 3.77
2026-07-31 10,667,818 12,134,646 -1,466,828 4.07
2026-07-15 12,134,646 12,443,449 -308,803 4.44
2026-06-30 12,443,449 11,133,208 +1,310,241 2.98
2026-06-15 11,133,208 11,588,307 -455,099 3.04
2026-05-29 11,588,307 12,683,834 -1,095,527 2.47
2026-05-15 12,683,834 13,816,927 -1,133,093 3.32
2026-04-30 13,816,927 12,011,065 +1,805,862 4.41
2026-04-15 12,011,065 11,520,329 +490,736 4.36
2026-03-31 11,520,329 11,579,085 -58,756 3.31
2026-03-13 11,579,085 12,161,157 -582,072 3.44
2026-02-27 12,161,157 13,443,797 -1,282,640 4.27
2026-02-13 13,443,797 26,462,455 -13,018,658 3.03
2026-01-30 26,462,455 27,513,663 -1,051,208 7.20
2026-01-15 27,513,663 28,800,189 -1,286,526 6.96
2025-12-31 28,800,189 27,721,192 +1,078,997 9.29
2025-12-15 27,721,192 24,331,177 +3,390,015 5.45
2025-11-28 24,331,177 24,029,541 +301,636 6.48
2025-11-14 24,029,541 14,193,421 +9,836,120 4.49
2025-10-31 14,193,421 13,575,761 +617,660 6.15

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1802768 CUSIP G7709Q104 13F (30d) 142 filings 130 filers Visit website Investor relations